Short term stroke outcome is worse among individuals with sickle cell trait

Background: Most (86%) of the global stroke mortality are from low- and middle-income countries (LMIC) including African countries which have the highest prevalence of the sickle cell trait (Hb AS). The effects of this trait on stroke occurrence and outcome are poorly understood. We aimed to investi...

Full description

Bibliographic Details
Main Authors: P. Olowoyo, M.O. Owolabi, B. Fawale, A. Ogunniyi
Format: Article
Language:English
Published: Elsevier 2016-06-01
Series:eNeurologicalSci
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650216300090
_version_ 1818456496050012160
author P. Olowoyo
M.O. Owolabi
B. Fawale
A. Ogunniyi
author_facet P. Olowoyo
M.O. Owolabi
B. Fawale
A. Ogunniyi
author_sort P. Olowoyo
collection DOAJ
description Background: Most (86%) of the global stroke mortality are from low- and middle-income countries (LMIC) including African countries which have the highest prevalence of the sickle cell trait (Hb AS). The effects of this trait on stroke occurrence and outcome are poorly understood. We aimed to investigate the effects of the sickle cell trait on the 30-day stroke mortality in Nigerian-Africans. Method: This was a prospective study of 35 stroke patients with sickle cell trait (Haemoglobin AS) and 35 age and sex-matched controls without haemoglobinopathy (Haemoglobin AA). Haemoglobin electrophoresis was performed for all before recruitment and they all had neuroimaging done. Patients with haemoglobin AS were used as cases and those with haemoglobin AA as controls. The National Institute of Health Stroke Scale (NIHSS) was used to assess the severity of stroke at presentation and the Modified Rankin Scale for 30-day stroke outcome. Result: There was no significant difference in the baseline stroke severity between the two groups (p = 0.21). Univariate analysis of the factors predicting the 30-day stroke outcome revealed that NIHSS score > 20 (p < 0.001), haemorrhagic stroke (p = 0.01) and the presence of Hb AS (p < 0.001) were significantly associated with 30-day mortality. Haemorrhagic stroke type was strongly associated with HbAS (OR = 2.9, 95% CI = 1.10–7.99, p-value = 0.02). With multiple logistic regression model, the presence of Hb AS (p = 0.01) and NIHSS score > 20 (p = 0.05) emerged as independent risk factors for 30-day mortality. The cases had worse stroke outcome at 30 days. Conclusion: Stroke had1 a worse 30-day mortality and outcome in patients with sickle cell trait (HbAS) than in patients with normal adult haemoglobin (HbAA).
first_indexed 2024-12-14T22:27:35Z
format Article
id doaj.art-f981fd5183bf4cc7b74bb3894811decd
institution Directory Open Access Journal
issn 2405-6502
language English
last_indexed 2024-12-14T22:27:35Z
publishDate 2016-06-01
publisher Elsevier
record_format Article
series eNeurologicalSci
spelling doaj.art-f981fd5183bf4cc7b74bb3894811decd2022-12-21T22:45:20ZengElseviereNeurologicalSci2405-65022016-06-013C646810.1016/j.ensci.2016.02.009Short term stroke outcome is worse among individuals with sickle cell traitP. Olowoyo0M.O. Owolabi1B. Fawale2A. Ogunniyi3Department of Medicine, Neurology Unit, Federal Teaching Hospital, Ido-Ekiti, NigeriaDepartment of Medicine, College of Medicine, University of Ibadan and University College Hospital, Ibadan, NigeriaNeurology Unit, Medicine Department, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, NigeriaDepartment of Medicine, College of Medicine, University of Ibadan and University College Hospital, Ibadan, NigeriaBackground: Most (86%) of the global stroke mortality are from low- and middle-income countries (LMIC) including African countries which have the highest prevalence of the sickle cell trait (Hb AS). The effects of this trait on stroke occurrence and outcome are poorly understood. We aimed to investigate the effects of the sickle cell trait on the 30-day stroke mortality in Nigerian-Africans. Method: This was a prospective study of 35 stroke patients with sickle cell trait (Haemoglobin AS) and 35 age and sex-matched controls without haemoglobinopathy (Haemoglobin AA). Haemoglobin electrophoresis was performed for all before recruitment and they all had neuroimaging done. Patients with haemoglobin AS were used as cases and those with haemoglobin AA as controls. The National Institute of Health Stroke Scale (NIHSS) was used to assess the severity of stroke at presentation and the Modified Rankin Scale for 30-day stroke outcome. Result: There was no significant difference in the baseline stroke severity between the two groups (p = 0.21). Univariate analysis of the factors predicting the 30-day stroke outcome revealed that NIHSS score > 20 (p < 0.001), haemorrhagic stroke (p = 0.01) and the presence of Hb AS (p < 0.001) were significantly associated with 30-day mortality. Haemorrhagic stroke type was strongly associated with HbAS (OR = 2.9, 95% CI = 1.10–7.99, p-value = 0.02). With multiple logistic regression model, the presence of Hb AS (p = 0.01) and NIHSS score > 20 (p = 0.05) emerged as independent risk factors for 30-day mortality. The cases had worse stroke outcome at 30 days. Conclusion: Stroke had1 a worse 30-day mortality and outcome in patients with sickle cell trait (HbAS) than in patients with normal adult haemoglobin (HbAA).http://www.sciencedirect.com/science/article/pii/S2405650216300090Stroke outcomeSickle cell traitStroke mortality
spellingShingle P. Olowoyo
M.O. Owolabi
B. Fawale
A. Ogunniyi
Short term stroke outcome is worse among individuals with sickle cell trait
eNeurologicalSci
Stroke outcome
Sickle cell trait
Stroke mortality
title Short term stroke outcome is worse among individuals with sickle cell trait
title_full Short term stroke outcome is worse among individuals with sickle cell trait
title_fullStr Short term stroke outcome is worse among individuals with sickle cell trait
title_full_unstemmed Short term stroke outcome is worse among individuals with sickle cell trait
title_short Short term stroke outcome is worse among individuals with sickle cell trait
title_sort short term stroke outcome is worse among individuals with sickle cell trait
topic Stroke outcome
Sickle cell trait
Stroke mortality
url http://www.sciencedirect.com/science/article/pii/S2405650216300090
work_keys_str_mv AT polowoyo shorttermstrokeoutcomeisworseamongindividualswithsicklecelltrait
AT moowolabi shorttermstrokeoutcomeisworseamongindividualswithsicklecelltrait
AT bfawale shorttermstrokeoutcomeisworseamongindividualswithsicklecelltrait
AT aogunniyi shorttermstrokeoutcomeisworseamongindividualswithsicklecelltrait